Gamot na May "Favipiravir" Ingredient, Clearly Effective' in Treating Coronavirus, Chinese officials claim
Loading...
Favipiravir,isang active na ingredient sa Japanese anti flu medicine na tinatawag na Avigan ay tinesting sa 340 na pasyente sa China na may Covid-19.
Ang pasyenteng nagamot ng favipiravir ay naka recover ng mas mabilis at nagpapakita ng malaking improvement sa baga kumpara sa mga pasyenteng hindi nagamot nito.
Ayon pa sa Daily Mail:
The component is thought to block the virus from replicating in the body.
Doses will be investigated in more COVID-19 patients by Hong Kong researchers, who claim they will give their pill 'for free' if studies show it is safe.
However, contradictory clinical trials suggest Favipiravir will not be useful in patients who have more severe illness.
As of yet, there isn't a treatment for the new coronavirus causing a global pandemic. Most people have mild symptoms and can recover at home within a week.
Almost 200,000 have been infected and 7,9000 have died.
Avipiravir is an active ingredient which has shown to be effective against flu strains, yellow fever, foot-and-mouth-disease and some other virus families.
It was given to 80 patients in Shenzen and in Wuhan, where the novel coronavirus first emerged in December 2019.
Favipiravir has been effective, with no obvious side-effects, in helping coronavirus patients recover, Zhang Xinmin, an official at China's Science and Technology Ministry, told reporters at a news conference on Tuesday.
'It has a high degree of safety and is clearly effective in treatment,' Mr Xinmin said, according to The Guardian.
Patients who were given the medicine in Shenzhen had negative results for the coronavirus an average of four days after being diagnosed, meaning there was no trace of the virus in their body.
This compared with 11 days for those who were not treated with the drug, according to local media.
X-rays showed improvements in lung condition in nine in ten of the patients who were treated with Favipiravir, compared to six in ten of those without the drug.
It is not clear what the results were in patients in Wuhan.
It's also unknown which branded Favipiravir drug the patients were given.
One of the most known is Avigan, manufactured by a subsidiary of Fujifilm, which is better known for its cameras. The drug was approved for use in Japan in 2014 as a new flu treatment.
SOURCE: DAILY MAIL
Loading...